Lura Health announces partnership with SCO Group to advance intraoral health monitoring through microsensors for saliva

The rapid development of wearable medical technologies in recent years has led to the emergence of unique solutions that expand the boundaries of traditional diagnostics. One of the most promising directions has been biosensing, enabling continuous health data collection outside clinical settings. Against this backdrop, the partnership between American company Lura Health — developer of the world’s first microsensors for real-time saliva monitoring — and Japanese technology corporation SCO Group represents a significant step in transforming dentistry, preventive medicine, and personalized healthcare.

The collaboration aims to integrate Lura Health’s intraoral sensors into clinical practice across Asian countries, primarily Japan, and to expand the global capabilities of technologies leveraging saliva’s diagnostic potential.

Technological breakthrough: intraoral sensors as a new source of biometric data

Lura Health is developing miniature wearable biosensors that can be placed directly inside the oral cavity:

• attach to orthodontic appliances;

• adhere to the tooth surface.

These devices enable continuous monitoring of key biomarkers — pH levels, metabolites, saliva parameters, and other indicators reflecting both oral and systemic health.

The company promotes the concept of “visualizing whole-body health through the oral environment,” emphasizing that saliva can serve as an informative, accessible, and non-invasive alternative to laboratory tests.

Context and partnership goals

Lura Health has developed the world’s first continuous saliva monitoring sensor and plans to obtain U.S. Food and Drug Administration (FDA) certification by early 2027. Following regulatory approval, the company aims to scale the technology across Asian markets.

SCO Group, for its part, is a key player in Japan’s digital dental services market and the operator of the Pay Light X platform — a comprehensive clinic management system encompassing scheduling, diagnostics, payments, and post-treatment patient follow-up.

Integrating Lura Health’s sensor technology into SCO Group’s infrastructure will enable the development and implementation of a new standard for preventive health monitoring in Japan, followed by other countries in the region.

Key aspects of the collaboration

1. Continuous monitoring via intraoral sensors

Lura Health sensors provide:

• real-time pH level tracking;

• measurement of salivary biochemical parameters;

• the ability to replace laboratory tests with daily monitoring.

This elevates saliva to a full-fledged diagnostic tool, providing access to data previously available only through blood tests or laboratory visits.

2. Integration via the Pay Light X platform

Through integration with SCO Group’s digital system, the technology is planned to be equipped with:

• dentists and primary care physicians;

• patients through clinical interfaces;

• researchers — as part of pilot projects.

Joint pilot studies with leading Japanese universities will begin this fall, enabling rapid clinical and user evaluation of the technology.

3. Applications beyond dentistry

Sensor application prospects include monitoring physical activity and athletic performance, tracking elderly patient conditions, and controlling metabolic and general biochemical indicators for chronic disease prevention.

Thus, intraoral sensors are positioned as a foundational element of future personalized health systems.

Parties’ positions: strategic vision

Daniel Weinstein, CEO of Lura Health, emphasized that the partnership with SCO Group is a major step toward expanding accessible and intuitive health monitoring:

“Our mission is to make saliva-based diagnostics a part of everyday medicine. Integration with SCO Group’s digital ecosystem will enable the use of our sensors in real-world clinical practice and create patient-centric products.”

Yusuke Tamai, Chairman and CEO of SCO Group, highlighted the significance of saliva as an underestimated yet highly informative biomaterial:

“The oral cavity is a window into the body’s condition. Merging our digital platform with Lura Health’s technology will transform hidden risks into clear and measurable indicators, creating a continuous model of preventive care.”

Conclusion

The partnership between Lura Health and SCO Group signifies a shift toward a new healthcare paradigm, in which:

• diagnostics become continuous and contactless,

• health data is collected in a natural environment without patient involvement,

• prevention takes center stage, reducing the burden on clinics and improving quality of life.

Intraoral sensors are not merely an innovation but the foundation of a new approach to health monitoring that integrates dentistry, digital medicine, and the personalized technologies of the future.